QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

NCT03387098 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention

Conditions

Pancreatic Cancer

Interventions

DRUG: Aldoxorubicin HCl
BIOLOGICAL: ALT-803
BIOLOGICAL: ETBX-011
BIOLOGICAL: GI-4000
BIOLOGICAL: haNK for infusion
BIOLOGICAL: avelumab
BIOLOGICAL: bevacizumab
DRUG: Capecitabine
DRUG: Cyclophosphamide
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: nab-Paclitaxel
DRUG: lovaza
DRUG: Oxaliplatin
PROCEDURE: SBRT

Sponsor

ImmunityBio, Inc.